MCID: PST095
MIFTS: 50

Post-Thrombotic Syndrome malady

Categories: Cardiovascular diseases, Blood diseases

Aliases & Classifications for Post-Thrombotic Syndrome

About this section

Aliases & Descriptions for Post-Thrombotic Syndrome:

Name: Post-Thrombotic Syndrome 11 13
Postphlebitic Syndrome 11 49 38 67
Postphlebetic Syndrome with Ulcer and Inflammation 11
Postphlebetic Syndrome with Inflammation 11
 
Postphlebetic Syndrome with Ulcer 11
Postthrombotic Syndrome 67
Venous Stress Disorder 11

Classifications:



External Ids:

Disease Ontology11 DOID:2364
ICD1029 I87.0
MeSH38 D011186

Summaries for Post-Thrombotic Syndrome

About this section
Disease Ontology:11 A venous insufficiency that is characterized by aching pain, heaviness, swelling, cramps, itching, or tingling in the affected limb and is a chronic complication of deep venous thrombosis.

MalaCards based summary: Post-Thrombotic Syndrome, also known as postphlebitic syndrome, is related to lymphedema and thrombophilia, and has symptoms including mahler sign An important gene associated with Post-Thrombotic Syndrome is F5 (Coagulation Factor V), and among its related pathways are Validated transcriptional targets of AP1 family members Fra1 and Fra2 and Immune response_MIF-mediated glucocorticoid regulation. Affiliated tissues include skin, testes and bone, and related mouse phenotypes are integument and cardiovascular system.

Wikipedia:70 Post-thrombotic syndrome (PTS), also called postphlebitic syndrome and venous stress disorder is a... more...

Related Diseases for Post-Thrombotic Syndrome

About this section

Diseases related to Post-Thrombotic Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 180)
idRelated DiseaseScoreTop Affiliating Genes
1lymphedema29.4F2, IL6, SERPINC1
2thrombophilia29.3F2, F5, IL6, SERPINC1
3chronic venous insufficiency11.1
4idiopathic neutropenia10.5F8, IL6
5acquired fructose intolerance10.4F5, F8
6arteriolosclerosis10.4ICAM1, IL6
7childhood central nervous system germinoma10.4F5, F8
8von willibrand disease, type 310.4F2, F8
9diabetic autonomic neuropathy10.4F2, F8
10wfs1-related disorders10.4F2, F8
11prostatic hypertrophy10.4F8, SERPINC1
12dementia - subcortical10.4ICAM1, IL6
13otopalatodigital syndrome, type i10.3F5, F8
14chronic diarrhea due to guanylate cyclase 2c overactivity10.3IL6, SERPINC1
15mastocytosis cutaneous with short stature conductive hearing loss and microtia10.3IL6, SERPINC1
16hepatic fibrosis renal cysts mental retardation10.3F5, SERPINC1
17classic congenital lipoid adrenal hyperplasia due to star deficency10.3F2, F5
18bartholin's gland adenoma10.3F2, F5
19colon carcinoma in situ10.3IL6, SERPINC1
20homocystinuria due to defect in methylation cbl g10.3F2, F5
21primary pigmented nodular adrenocortical disease10.3F2, F5
22van maldergem syndrome 210.3F2, F8
23hepatocellular adenoma10.2F2, F5
24ariboflavinosis10.2F2, SERPINC1
25myiasis10.2F2, SERPINC1
26cavernous hemangioma of face10.2F2, SERPINC1
27ovarian gonadoblastoma10.2F2, SERPINC1
28angioedema, hereditary, type iii10.2F5, SERPINC1
29milk allergy10.2F2, SERPINC1
30spleen cancer10.2F2, SERPINC1
31scapuloperoneal myopathy, x-linked dominant10.2F2, F8
32dmd-related dilated cardiomyopathy10.2F2, SERPINC1
33congenital stenosis of the inferior vena cava10.2F5, SERPINE1
34ameloblastic carcinoma10.2F5, SERPINE1
35irak4 deficiency10.2F2, F5
36lymphatic system cancer10.2F2, SERPINC1
37noma10.2F2, F5
38chronic apical periodontitis10.2IL6, SERPINC1
39lujo hemorrhagic fever10.2F2, SERPINC1
40chromophobe adenoma10.2ICAM1, SERPINE1
41catatrichy10.2F5, SERPINE1
42oppositional defiant disorder10.2ICAM1, SERPINE1
43anterior foramen magnum meningioma10.2F2, SERPINC1
44retinal dystrophy, iris coloboma, and comedogenic acne syndrome10.2F5, SERPINE1
45intracranial arteriosclerosis10.2F2, SERPINC1
46spastic paraplegia 3a10.1F2, F5
47thrombocytopenia with elevated serum iga and renal disease10.1F2, F5
48cutaneous porphyria10.1F2, IL6
49dermatitis10.1F2, SERPINC1
50neurogenic bowel10.1F2, IL6

Comorbidity relations with Post-Thrombotic Syndrome via Phenotypic Disease Network (PDN):


Heart DiseaseHypertension, Essential
Ischemic Heart DiseasePeripheral Vascular Disease
Acute CystitisVenous Insufficiency

Graphical network of the top 20 diseases related to Post-Thrombotic Syndrome:



Diseases related to post-thrombotic syndrome

Symptoms for Post-Thrombotic Syndrome

About this section

UMLS symptoms related to Post-Thrombotic Syndrome:


mahler sign

Drugs & Therapeutics for Post-Thrombotic Syndrome

About this section

Drugs for Post-Thrombotic Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 94)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Nitric OxideapprovedPhase 4, Phase 259910102-43-9145068
Synonyms:
(.)NO
(NO)(.)
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous Nitrate Vasodilator
Endothelium-Derived Nitric Oxide
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, Mononitrogen
Monoxide, Nitrogen
Monoxido de nitrogeno
Monoxyde d'azote
NITRIC-OXIDE
NO
NO(.)
Nitrate Vasodilator, Endogenous
Nitric Oxide, Endothelium Derived
 
Nitric Oxide, Endothelium-Derived
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
OHM 11771
Oxide, Nitric
Oxido de nitrogeno(ii)
Oxido nitrico
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoff(ii)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, Endogenous Nitrate
[NO]
endothelium-derived relaxing factor
monoxido de nitrogeno
monoxyde d'azote
nitric oxide
nitrogen monooxide
nitrogen monoxide
nitrosyl
oxido de nitrogeno(II)
oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
2
DalteparinapprovedPhase 4, Phase 33039041-08-1
Synonyms:
Daltepariininatrium
Dalteparin Sodyum
Dalteparin sodium
Dalteparin sodná sůl
Dalteparin-nátrium
Dalteparina sódica
 
Dalteparinnatrium
Dalteparino natrio druska
Dalteparinum Natricum
Dalteparyna sodowa
Daltéparine sodique
Heparin Fragment KABI 2165
Tedelparin
3
Heparinapproved, investigationalPhase 4, Phase 3, Phase 1, Phase 28129005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Unfractionated heparin
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin
4
Glucosamineapproved, NutraceuticalPhase 4, Early Phase 11823416-24-8439213
Synonyms:
(+)-2-amino-2-deoxy-D-glucopyranose
(2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(2S,5R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
14257-69-3
2-Amino-2-deoxy-D-Glucose
2-Amino-2-deoxy-D-glucopyranose
2-Amino-2-deoxy-D-glucose
2-Amino-2-deoxy-beta-D-glucopyranose
2-Amino-2-deoxyglucose
2-Aminoglucose
2-Deoxy-2-amino-D-glucose
2-Deoxy-2-aminoglucose
2-amino-2-deoxy-D-glucopyranose
2-amino-2-deoxyglucose
2351-15-7
28905-10-4
2B4D44B2-D5AC-4DA4-9BE6-A4AE9574E4A6
3416-24-8
4-04-00-02017 (Beilstein Handbook Reference)
58-87-7
58267-75-7
6490-70-6
880765-44-6
90-77-7
911653-84-4
AC1L2D1C
AC1L96WB
AC1L9B8P
AC1Q4UBH
BRN 1724602
BSPBio_002086
C00329
C08349
CHEBI:28393
CHEBI:47977
CHEMBL234432
CID18897
CID439213
CID441477
CPD0-1193
Chitosamine
Cosamin
D-(+)-Glucosamine
 
D-Glucosamine
D-glucosamine
D04334
DB01296
DivK1c_000261
EINECS 222-311-2
GCS
Glucosamina
Glucosamina [INN-Spanish]
Glucosamine (USAN/INN)
Glucosamine [USAN:INN]
Glucosaminum
Glucosaminum [INN-Latin]
HMS500N03
HSDB 7469
IDI1_000261
InChI=1/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6-/m1/s1
KBio1_000261
KBio2_001311
KBio2_003879
KBio2_006447
KBio3_001306
KBioGR_000970
KBioSS_001311
LS-71671
MolPort-002-507-091
MolPort-003-944-937
NCGC00164421-01
NCGC00178826-01
NINDS_000261
SPBio_000477
STK801823
Spectrum2_000519
Spectrum3_000443
Spectrum4_000565
Spectrum5_000756
Spectrum_000831
Viartril-S
beta-D-Glucosamine
bmse000247
chitosamine
glucosamine
nchembio.189-comp4
nchembio.2007.41-comp7
nchembio.412-comp5
partially N-deacetylated poly-beta-1,6-N-acetyl-D-glucosamine
5Pharmaceutical SolutionsPhase 4, Phase 3, Phase 27793
6AnticoagulantsPhase 4, Phase 3, Phase 1, Phase 22516
7calcium heparinPhase 4, Phase 3812
8AnestheticsPhase 4, Phase 29001
9Fibrinolytic AgentsPhase 4, Phase 32317
10Heparin, Low-Molecular-WeightPhase 4, Phase 3320
11Lipid Regulating AgentsPhase 4, Phase 1, Phase 22702
12Hypoglycemic AgentsPhase 45733
13Hypolipidemic AgentsPhase 4, Phase 1, Phase 22721
14AntimetabolitesPhase 4, Phase 1, Phase 211774
15Glucuronyl glucosamine glycan sulfatePhase 4132
16
WarfarinapprovedPhase 3, Phase 1, Phase 245481-81-26691, 54678486
Synonyms:
(-)-Warfarin
(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone
(S)-Warfarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine
1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone
200 Coumarin
200 coumarin
3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin
3-(Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin
3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin
4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin
4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine
45706_FLUKA
45706_RIEDEL
4oh-coumarin deriv.
5543-56-6
5543-57-7
81-81-2
A2250_FLUKA
A2250_SIGMA
AC-15978
AC1L1N37
AC1Q6AN3
AR-1E2310
Arab Rat Death
Arab rat death
Arab rat deth
Athrombin
Athrombin-K
Athrombin-k
Athrombine-K
Athrombine-k
BRD-A24514565-001-02-2
BRD-A24514565-236-01-6
BRN 1293536
BSPBio_002026
Bio-0586
Brumolin
C01541
C19H16O4
CBDivE_002127
CBDivE_013236
CBKinase1_000192
CBKinase1_012592
CHEBI:10033
CHEMBL1464
CID6691
CO-Rax
Caswell No. 903
Choice
Choice (TN)
Co-Rax
Co-rax
Compound 42
Coumadin
Coumadin Tabs
Coumafen
Coumafene
Coumafene [French]
Coumaphen
Coumaphene
Coumarins
Coumefene
Cov-R-Tox
Cov-R-tox
D-Con
D08682
DB00682
DL-3-(alpha-acetonylbenzyl)-4-hydroxycoumarin
Dethmor
Dethnel
Dicusat E
Dicusat e
DivK1c_000444
EINECS 201-377-6
EINECS 226-907-3
EPA Pesticide Chemical Code 086002
Eastern states duocide
Fasco fascrat powder
Frass-Ratron
Frass-ratron
HMS1921K07
HMS2092C20
HMS501G06
HSDB 1786
I14-0958
IDI1_000444
Jantoven
KBio1_000444
KBio2_000674
KBio2_003242
KBio2_005810
KBio3_001526
KBioGR_000901
KBioSS_000674
Killgerm sewarin p
Kumader
Kumadu
Kumatox
Kypfarin
LS-55083
Latka 42
Latka 42 [Czech]
Liqua-tox
MLS001304042
Maag Rattentod Cum
Maag rattentod cum
Mar-Frin
Mar-frin
Marevan
Martin'S mar-frin
Martin's mar-frin
 
Maveran
MolPort-001-787-822
Mouse pak
NCGC00094810-01
NCGC00094810-02
NCGC00159398-03
NCGC00178855-01
NINDS_000444
NSC 59813
NSC59813
PS104_SUPELCO
Panwarfin
Place-Pax
Place-pax
Prothromadin
RAX
RCR grey squirrel killer concentrate
RCRA waste no. P001
Rat & mice bait
Rat and mice bait
Rat-B-gon
Rat-Gard
Rat-Kill
Rat-Mix
Rat-O-cide #2
Rat-O-cide no. 2
Rat-Ola
Rat-Trol
Rat-a-way
Rat-alpha-way
Rat-b-gon
Rat-beta-gon
Rat-gard
Rat-kill
Rat-mix
Rat-o-cide #2
Rat-ola
Rat-trol
Ratorex
Ratox
Ratoxin
Ratron
Ratron G
Ratron g
Rats-no-more
Ratten-Koederrohr
Ratten-koederrohr
Rattenstreupulver Neu Schacht
Rattenstreupulver neu schacht
Rattenstreupulver new schacht
Rattentraenke
Rattunal
Rcra waste number P001
Ro-Deth
Ro-deth
Rodafarin
Rodafarin C
Rodafarin c
Rodex
Rodex blox
Rosex
Rough & ready mouse mix
Rough and ready mouse mix
SMP1_000316
SMR000718754
SPBio_000870
SPECTRUM1500613
STK364490
Sakarat
Sewarin
Sofarin
Solfarin
Sorexa Plus
Sorexa plus
Spectrum2_000935
Spectrum3_000583
Spectrum4_000381
Spectrum5_001751
Spectrum_000194
Spray-trol brand roden-trol
Temus W
Temus w
Tintorane
Tox-Hid
Tox-hid
Twin light rat away
UNII-5Q7ZVV76EI
Vampirinip II
Vampirinip III
Vampirinip iii
W.A.R.F. 42
WARF compound 42
WLN: T66 BOVJ DYR&1V1 EQ
Waran
Warf 10
Warf 42
Warfarat
Warfarin (INN)
Warfarin (and salts of)
Warfarin Plus
Warfarin Q
Warfarin [BSI:ISO]
Warfarin [INN:BAN]
Warfarin plus
Warfarin plus [discontinued]
Warfarin sodium
Warfarin titrated to an INR of 2.5-3.0
Warfarin(R)
Warfarina
Warfarina [INN-Spanish]
Warfarine
Warfarine [INN-French]
Warfarine [ISO-French]
Warfarinum
Warfarinum [INN-Latin]
Warficide
Warfilone
Zoocoumarin
Zoocoumarin [Netherlands and USSR]
Zoocoumarin [Russian]
delta-Con
nchembio.307-comp19
rac-Warfarin
warfarin
17
BenzocaineapprovedPhase 318921994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
18
TinzaparinapprovedPhase 3379005-49-6, 9041-08-125244225
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
37324-73-5
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID8784
CY 216
Certoparin
Clivarin
Clivarine
Cy 222
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
Enoxaparin sodium
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
 
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
heparin
19NadroparinapprovedPhase 3359041-08-1
20
TenecteplaseapprovedPhase 340191588-94-0
Synonyms:
191588-94-0
D06070
Tenecteplase
Tenecteplase (USAN/INN)
 
Tissue-type plasminogen activator precursor
Tnkase
Tnkase (TN)
t- PA
t-plasminogen activator
tPA
21
Phytonadioneapproved, NutraceuticalPhase 323084-80-04812, 5284607
Synonyms:
.alpha.-Phylloquinone
1,4-Naphthalenedione, 2-methyl-3-((2E,7R,11R)-3,7,11,15-tetramethyl-2-hexadecenyl)-, radical ion(1-)
10485-69-5
11104-38-4
15973-57-6
2', 3'-trans-Vitamin K1
2',3'-trans-Vitamin K1
2-(3,7,11,15-Tetramethylhexadec-2-enyl)-3-methylnaphthalene-1,4-dione
2-METHYL-3-PHYTYL-14-NAPHTHOQUINONE
2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalened- ione
2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione
2-Methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)-1,4-naphthoquinone
2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone
2-Methyl-3-phythyl-1,4-naphthochinon
2-Methyl-3-phytyl-1,4-naphthochinon
2-Methyl-3-phytyl-1,4-naphthochinon [German]
2-Methyl-3-phytyl-1,4-naphthoquinone
2-methyl-3-(3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione
2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
27696-10-2
3-Phytylmenadione
50926-17-5
84-80-0
AC1NQX34
AC1Q6B3J
AR-1E3503
Antihemorrhagic vitamin
Aqua mephyton
Aqua-Mephytin
Aquamephyton
C02059
C31H46O2
CID5280483
Combinal K1
D00148
DB01022
EINECS 201-564-2
EINECS 234-330-3
EINECS 279-833-9
Fitomenadiona
Fitomenadiona [INN-Spanish]
Fitomenadione
Fitomenadione [DCIT]
HSDB 3162
K-Ject
Kativ N
Kephton
 
Kinadion
Konakion
LS-94617
LT00452032
MLS001332659
MLS001332660
Mephyton
Mephyton (TN)
MolPort-001-785-978
Mono-Kay
Monodion
NCGC00159423-02
NSC 270681
NSC270681
P0642
Phyllochinon
Phyllochinon [German]
Phyllochinonum
Phylloquinone
Phylloquinone (8CI)
Phythyl-menadion
Phythyl-menadion (GERMAN)
Phytomenadione
Phytomenadione (INN)
Phytomenadionum
Phytomenadionum [INN-Latin]
Phytonadione
Phytonadione (JP15/USP)
Phytonadione [USAN:JAN]
Phytonadionum
Phytylmenadione
SMR000059144
ST075162
Synthex P
UNII-A034SE7857
VITAMIN K
VITAMIN K1
Vitamin K
Vitamin K 1
Vitamin K1
Vitamin K1 (TN)
Vitamin K1 (VAN)
Vitamin K1 (generic)
Vitamin K1(20)
alpha-Phylloquinone
phyllohydroquinone
phytonadione
trans-Phylloquinone
α-phylloquinone
22
Menadioneapproved, nutraceuticalPhase 323058-27-54055
Synonyms:
03AAE1E9-B215-45AF-976C-91E61894A467
1,4-Naphthalenedione, 2-methyl-, radical ion(1-)
2-Methyl-1,4-Naphthalenedione
2-Methyl-1,4-naftochinon
2-Methyl-1,4-naftochinon [Czech]
2-Methyl-1,4-naphthalendione
2-Methyl-1,4-naphthalenedione
2-Methyl-1,4-naphthochinon
2-Methyl-1,4-naphthochinon [German]
2-Methyl-1,4-naphthodione
2-Methyl-1,4-naphthoquinone
2-Methylnaphthoquinone
2-methyl-1,4-naphthoquinone, 5
2-methylnaphthalene-1,4-dione
3-Methyl-1,4-naphthoquinone
34524-96-4
47775_SUPELCO
58-27-5
72060-21-0
AC1L1HBA
AC1Q2HB3
AI3-14700
AKOS004910447
ARONIS24154
Aquakay
Aquinone
BB_NC-2319
BIDD:ER0556
BPBio1_000592
BSPBio_000538
Bio1_000471
Bio1_000960
Bio1_001449
C05377
C11H8O2
CAS-58-27-5
CCRIS 6672
CHEBI:28869
CHEMBL590
CID4055
CPD-3766
D02335
DB00170
DivK1c_000080
DivK1c_006287
EINECS 200-372-6
HMS1569K20
HMS1921P06
HMS2092F12
HMS500D22
HSDB 3354
Hemodal
I14-2821
IDI1_000080
InChI=1/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H
Juva-K
K-Thrombyl
K-Vitan
KBio1_000080
KBio1_001231
KBio2_001708
KBio2_002527
KBio2_004276
KBio2_005095
KBio2_006844
KBio2_007663
KBio3_003005
KBioGR_000984
KBioGR_002527
KBioSS_001708
KBioSS_002535
Kaergona
Kanone
Kappaxan
Kappaxan (VAN)
Kappaxin
Kappaxin (TN)
Karcon
Kareon
Kativ-G
Kayklot
Kaykot
 
Kaynone
Kayquinone
Kipca
Kipca, oil soluble
Kipca-Oil Soluble
Klottone
Koaxin
Kolklot
LS-95653
LS-95654
M0373
M5625_SIGMA
M9429_SIGMA
MLS000069420
MLS001148443
MNQ
Memodol
Menadion
Menadione
Menadione (K3)
Menadione (USP)
Menadione [USAN:BAN]
Menadione semiquinone
Menadionum
Menaphthene
Menaphthon
Menaphthone
Menaphtone
Menaquinone
Menaquinone 0
Menaquinone O
Methyl-1,4-naphthalenedione
Methyl-1,4-naphthoquinone
Methylnaphthoquinone
Mitenon
Mitenone
MolPort-001-766-699
NCGC00016258-01
NCGC00094978-01
NCGC00094978-02
NCI60_003945
NCIMech_000105
NINDS_000080
NSC 4170
NSC4170
Panosine
Prestwick0_000459
Prestwick1_000459
Prestwick2_000459
Prestwick3_000459
Prestwick_313
Prokayvit
QTL1_000056
S1949_Selleck
SMR000059102
SMR000653532
SPBio_001267
SPBio_002477
SPECTRUM1502254
SpecPlus_000191
Spectrum2_001194
Spectrum4_000722
Spectrum5_001764
Spectrum_001228
Synkay
Thyloquinone
UNII-723JX6CXY5
Usaf ek-5185
VK3
Vicasol
Vitamin K 3
Vitamin K0
Vitamin K2
Vitamin K2(0)
Vitamin K3
Vitamin K3 : 2-Methyl-1,4-naphthoquinone
Vitamin K3: 1,4-Dihydro-1,4-dioxo-2-methylnaphthalene
Vitamin-?K3
WLN: L66 BV EVJ C1
ZINC00001677
cMAP_000077
menadione
nchembio.109-comp5
23tannic acidapproved, NutraceuticalPhase 31892
24Serine Proteinase InhibitorsPhase 3850
25Antithrombin IIIPhase 3665
26HIV Protease InhibitorsPhase 35319
27
protease inhibitorsPhase 35320
Synonyms:
 
protease inhibitors
28AntithrombinsPhase 3672
29VitaminsPhase 3, Phase 25095
30HemostaticsPhase 31359
31ThrombinPhase 3, Phase 2288
32CoagulantsPhase 31428
33Tissue Plasminogen ActivatorPhase 3231
34Calcium, DietaryPhase 3, Phase 2, Phase 15525
35AntibodiesPhase 36045
36ImmunoglobulinsPhase 36045
37Antibodies, AntiphospholipidPhase 329
38DabigatranPhase 3221
39PlasminogenPhase 3236
40MenaquinoneNutraceuticalPhase 3230
41KavanutraceuticalPhase 31489000-38-8
42naphthoquinoneNutraceuticalPhase 3230
43Vitamin KNutraceuticalPhase 3231
44serineNutraceuticalPhase 3921
45Methyl salicylateapprovedPhase 212
46
Pyridoxalapproved, nutraceuticalPhase 218566-72-81050
Synonyms:
2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine
3-Hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde
3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde
 
3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde
3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde
Piridoxal
Pyridoxal
Pyridoxaldehyde
47
Pyridoxineapproved, nutraceutical, vet_approvedPhase 218665-23-61054
Synonyms:
(5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate
12001-78-4
2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine
2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine
2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin
2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin [German]
2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine
2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine
2-methyl-3-hydroxy-4,5-bis(hydroxy-methyl) pyridine
2-methyl-3-hydroxy-4,5-dihydroxymethylpyridine
2-methyl-4,5-dimethylol-pyridin-3-ol
2B3E07D2-E4CC-4CC5-B085-6070BA01F9F0
3,4-Pyridinedimethanol, 5-hydroxy-6-methyl-, hydrochloride
3-Hydroxy-2-Picoline-4,5-dimethanol
3-Hydroxy-4,5-dihydroxymethyl-2-methylpyridine hydrochloride
3-Hydroxy-4,5-dimethylol-.alpha.-picoline hydrochloride
3-Hydroxy-4,5-dimethylol-alpha-picoline
3-Hydroxy-4,5-dimethylol-alpha-picoline hydrochloride
3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine
4,5-Bis(hydroxymethyl)-2-methyl-3-pyridinol
4,5-Bis(hydroxymethyl)-2-methylpyridin-3-ol hydrochloride
4,5-bis(hydroxymethyl)-2-methyl-3-pyridinol hydrochloride
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol
4,5-bis(hydroxymethyl)-2-methylpyridine-3-ol
4-Deoxypyridoxine 5'-phosphate
47862_SUPELCO
5-Hydroxy-6-methyl-3,4-pyridinedicarbinol hydrochloride
5-Hydroxy-6-methyl-3,4-pyridinedimethanol
5-Hydroxy-6-methyl-3,4-pyridinedimethanol hydrochloride
5-Hydroxy-6-methyl-3,4-pyridinedimethanol, hydrochloride
58-56-0
58-56-0 (HCL)
58-56-0 (hydrochloride)
65-23-6
65-23-6 (Parent)
8059-24-3
85078-23-5
AC-12024
AC-14512
AC-907/25014218
AC1L1AMH
AC1L1LMI
AC1L2XK2
AC1Q22HP
AC1Q2G66
AC1Q3F63
AI3-19016
AIDS-006784
AIDS006784
AR-1A6363
AR-1J1632
Adermin hydrochloride
Adermine
Adermine hydrochloride
Aderomine hydrochloride
Aderoxin
Aderoxine
Alestrol
BB_NC-0050
BIDD:PXR0180
BPBio1_000646
BSPBio_000586
Becilan
Beesix
Benadon
Bonasanit
C00314
C8H11NO3
CAS-58-56-0
CBDivE_015627
CCRIS 1903
CHEBI:16709
CHEBI:30961
CHEMBL1200756
CHEMBL1364
CID104817
CID1054
CID6019
CPD0-1221
Campoviton 6
Cernevit-12
D02179
D025101
D08454
DB00165
EINECS 200-386-2
EINECS 200-603-0
EINECS 232-503-8
Godabion
Gravidox
HMS1569N08
HMS2093L07
HSDB 1212
Hexa-Betalin
Hexa-Betalin (R)
Hexa-betalin (TN)
Hexabetalin
Hexabione hydrochloride
 
Hexavibex
Hexermin
Hexermine
Hexobion
Hydoxin
I02-1897
I02-2297
KST-1A8556
LS-134393
LS-187072
LS-2332
MLS001074329
MLS002153915
MolPort-002-137-856
MolPort-002-319-991
MolPort-005-933-330
NCGC00016261-01
NCGC00164317-01
NCGC00180946-01
NSC 36225
NSC36225
NSC36225 (HCL)
Nestrex
Oprea1_061614
P0561
P4722_SIAL
P5669_SIGMA
P6280_SIGMA
P8666_SIGMA
P9755_SIAL
PN
PN HCl
PYRIDOXINE HYDROCHLORIDE
PYRIDOXINE HYDROCHLORIDE, U.S.P.
Paxadon
Piridossina
Piridossina [DCIT]
Piridoxina
Piridoxina [INN-Spanish]
Prestwick0_000623
Prestwick1_000623
Prestwick2_000623
Prestwick3_000623
Prestwick_925
Pydox
Pyridipca
Pyridox
Pyridoxin
Pyridoxin hydrochloride
Pyridoxine
Pyridoxine (INN)
Pyridoxine HCl
Pyridoxine Hydrochloride (B6)
Pyridoxine [INN:BAN]
Pyridoxine chloride
Pyridoxine hydrochloride (JP15/USP)
Pyridoxine hydrochloride [USAN:JAN]
Pyridoxine hydrogen chloride
Pyridoxine monohydrochloride
Pyridoxine, hydrochloride
Pyridoxine-HCl Microencapsulated
Pyridoxinium chloride
Pyridoxinum
Pyridoxinum [INN-Latin]
Pyridoxinum hydrochloricum
Pyridoxinum hydrochloricum (Hungarian)
Pyridoxol
Pyridoxol hydrochloride
Pyridoxol, hydrochloride
Pyridoxolum
Rodex
Rodex (R)
Rodex TD
SMP2_000230
SMR000674613
SPBio_002805
STK177324
STOCK1N-08684
Spondylonal
Tex Six T.R.
TimTec1_000657
UNII-68Y4CF58BV
UNII-KV2JZ1BI6Z
Vitamin B 6
Vitamin B6
Vitamin B6-hydrochloride
Vitamin V6
Vitamin V6 (TN)
Vitamin-?B6
Vitamin-?B6 hydrochloride
Vitaped
WLN: T6NJ B1 CQ D1Q E1Q &GH
ZINC00049154
ZINC21983293
bmse000288
c1302
component of Alestrol
nchembio.93-comp1
pyridoxine
vitamin B6
48
Folic Acidapproved, nutraceutical, vet_approvedPhase 2427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
49Peripheral Nervous System AgentsPhase 222776
50Vitamin B ComplexPhase 24229

Interventional clinical trials:

(show top 50)    (show all 125)
idNameStatusNCT IDPhase
1Clinical Evaluation of the SNaP Wound Care SystemUnknown statusNCT01113658Phase 4
2Global Vascular Effects of Intermittent Pneumatic Compression-Pilot StudyUnknown statusNCT01064323Phase 4
3Two Weeks of Low Molecular Weight Heparin for Distal Vein ThrombosisUnknown statusNCT01252420Phase 4
4OASIS Wound Matrix (Oasis) Mechanism of ActionCompletedNCT00570141Phase 4
5Practicability of Gliding Aids for Medical Compression StockingsCompletedNCT01432795Phase 4
6DermACELL in Subjects With Chronic Wounds of the Lower ExtremitiesCompletedNCT01970163Phase 4
7Wound Fluid Protease Levels During Use of Novel Wound DressingCompletedNCT01567150Phase 4
8Skin Ulcers Treatment With an Handicraft Topical DeviceCompletedNCT02512159Phase 4
9Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and SulodexideRecruitingNCT02512601Phase 4
10Outcome of Percutaneous Mechanical Thrombectomy to Treat Acute Deep Venous ThrombosisRecruitingNCT02959801Phase 4
11Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)RecruitingNCT02470806Phase 4
12Juxta-CuresTM Versus Bandaging for Venous UlcersNot yet recruitingNCT02790593Phase 4
13Flexitouch Compression System for Venous Stasis UlcerTerminatedNCT00534937Phase 4
14Flexitouch Treatment for Venous UlcersTerminatedNCT00847002Phase 4
15Pulsed Electromagnetic Fields (PEMF) and Post-Axillary Surgery MorbidityTerminatedNCT01255631Phase 4
16Treatment Trial for Post-Thrombotic SyndromeUnknown statusNCT00633971Phase 3
17DUTCH CAVA-trial: CAtheter Versus Anticoagulation Alone for Acute Primary (Ilio)Femoral DVT.Unknown statusNCT00970619Phase 3
18Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2Unknown statusNCT01737762Phase 3
19Evaluation of a Venous-Return Assist Device (Venowave) to Treat Post-Thrombotic Syndrome: A Randomized Controlled TrialCompletedNCT00182208Phase 3
20The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic SyndromeCompletedNCT00143598Phase 3
21Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) TrialCompletedNCT01615705Phase 3
22Full-Leg vs Below-Knee Elastic Stockings for Prevention of the Post-Thrombotic SyndromeCompletedNCT00426075Phase 3
23Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower ExtremitiesCompletedNCT00628576Phase 3
24Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg UlcersCompletedNCT01656889Phase 3
25Pivotal Trial of Dermagraft(R) to Treat Venous Leg UlcersCompletedNCT00909870Phase 3
26Elastic Compression Stockings for Prevention of Post-thrombotic SyndromeRecruitingNCT01578122Phase 3
27Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)RecruitingNCT00421538Phase 3
28Safety And Efficacy Of Topical Platelet Rich Plasma And Thrombin CoagulumRecruitingNCT02802995Phase 3
29Evaluation of the Duration of Therapy for Thrombosis in ChildrenRecruitingNCT00687882Phase 3
30Safety of Dabigatran Etexilate in Blood Clot Prevention in ChildrenRecruitingNCT02197416Phase 3
31Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)RecruitingNCT01895777Phase 3
32Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed ThrombolysisActive, not recruitingNCT00790335Phase 3
33Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247Active, not recruitingNCT01970657Phase 3
34Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes TrialNot yet recruitingNCT02767232Phase 3
35Clinical Trial of ECLIPSE PRP™ Wound Biomatrix in Chronic Non-Healing Venous Leg UlcersNot yet recruitingNCT02312518Phase 2, Phase 3
36EVENT: Hydrotherapy and Deep Venous ThrombosisTerminatedNCT00348907Phase 3
37Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg UlcersTerminatedNCT01853384Phase 3
38Clot Dissolving Treatment for Blood Clots in the LungsTerminatedNCT00680628Phase 3
39Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical PatientsWithdrawnNCT00912483Phase 3
40Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac SurgeryWithdrawnNCT01474902Phase 3
41The Use of Intermittent Pneumatic Compression Device for Symptomatic Relief in Patients With Post Thrombotic SyndromeUnknown statusNCT01637428Phase 2
42Study of Thymosin Beta 4 in Patients With Venous Stasis UlcersCompletedNCT00832091Phase 2
43Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic SyndromeCompletedNCT00858130Phase 2
44Dose Finding Study of HP802-247 in Venous Leg UlcersCompletedNCT00852995Phase 2
45The Effect of the Cosmetic Cream NMBM on Leg Ulcers - a Pilot StudyCompletedNCT01770509Phase 1, Phase 2
46The Efficacy of Venavine Intensive® on the Quality of Life in Females With Chronic Venous InsufficiencyCompletedNCT02498327Phase 2
47Role of a Novel Exercise Program to Prevent Post-thrombotic SyndromeRecruitingNCT02148029Phase 1, Phase 2
48Clinical Trial to Investigate Efficacy and Safety of the IMP in Patients With Non Healing Wounds Originating From UlcersRecruitingNCT02742844Phase 1, Phase 2
49Statin Use in Patients With Acute VTERecruitingNCT02331095Phase 1, Phase 2
50Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized StudyRecruitingNCT02128178Phase 1, Phase 2

Search NIH Clinical Center for Post-Thrombotic Syndrome


Cochrane evidence based reviews: postphlebitic syndrome

Genetic Tests for Post-Thrombotic Syndrome

About this section

Anatomical Context for Post-Thrombotic Syndrome

About this section

MalaCards organs/tissues related to Post-Thrombotic Syndrome:

35
Skin, Testes, Bone, Lung, Heart, Brain, Endothelial

Animal Models for Post-Thrombotic Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Post-Thrombotic Syndrome:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107718.9F2, F5, ICAM1, IL6, SERPINE1
2MP:00053858.1F2, F5, ICAM1, IL6, SERPINC1, SERPINE1
3MP:00053978.1F2, F8, ICAM1, IL6, SERPINC1, SERPINE1
4MP:00053767.7F2, F5, F8, ICAM1, IL6, SERPINC1
5MP:00053877.6CCL2, F2, F8, ICAM1, IL6, SERPINC1
6MP:00107686.9F2, F5, F8, ICAM1, IL6, SERPINC1

Publications for Post-Thrombotic Syndrome

About this section

Articles related to Post-Thrombotic Syndrome:

(show top 50)    (show all 91)
idTitleAuthorsYear
1
One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomised controlled trial. (27245485)
2016
2
Efficacy of compression for the prevention of post-thrombotic syndrome: an unsolved clinical conundrum Comment on Burgstaller et al, p. 141 - 147. (27058794)
2016
3
The role of inflammation in post-thrombotic syndrome after pregnancy-related deep vein thrombosis: A population-based, cross-sectional study. (26826503)
2016
4
Systematic Review and Meta-Analysis of Utility of Graduated Compression Stockings in Prevention of Post-Thrombotic Syndrome. (27026391)
2016
5
Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular BehAset's disease. (27318049)
2016
6
Relationship between development of post-thrombotic syndrome and serial ultrasound, D-dimer, and factor VIII activity after a first deep venous thrombosis. (26946892)
2016
7
Guidance for the prevention and treatment of the post-thrombotic syndrome. (26780743)
2016
8
Effect of compression stockings on post thrombotic syndrome in patients with deep vein thrombosis: a meta-analysis of randomised controlled trials. (27264039)
2016
9
Post-thrombotic syndrome and the risk of subsequent recurrent thromboembolism. (26986754)
2016
10
Inter-rater agreement between professional-rated and patient-rated scores of the Villalta scale for evaluation of the post-thrombotic syndrome. (27058275)
2016
11
Understanding the barriers in compliance to elastic compression garments in the treatment of pediatric post-thrombotic syndrome: A qualitative study. (27318248)
2016
12
Time taken to the maximum increase in the oxygenated hemoglobin level in calf muscle as a predictor of mild and moderate post-thrombotic syndrome. (27638999)
2016
13
Oral anticoagulants, effect on thrombus resolution and post-thrombotic syndrome. (26916765)
2016
14
The post-thrombotic syndrome. (27913509)
2016
15
Prevention of the Post-Thrombotic Syndrome. (27311456)
2016
16
Pediatric post-thrombotic syndrome in children: Toward the development of a new diagnostic and evaluative measurement tool. (27393923)
2016
17
Deep vein thrombosis resolution, recurrence and post-thrombotic syndrome: a prospective observational study protocol. (27651905)
2016
18
Diagnosis of deep vein thrombosis, and prevention of deep vein thrombosis recurrence and the post-thrombotic syndrome in the primary care medicine setting anno 2014. (25685720)
2015
19
Low incidence of post-thrombotic syndrome in patients treated with new oral anticoagulants and percutaneous endovenous intervention for lower extremity deep venous thrombosis. (25832599)
2015
20
Prevalence and risk factors for post thrombotic syndrome after deep vein thrombosis in children: a cohort study. (25528070)
2015
21
Plasma MMP and TIMP evaluation in patients with deep venous thrombosis: could they have a predictive role in the development of post-thrombotic syndrome? (26403997)
2015
22
Does prescription of medical compression prevent development of post-thrombotic syndrome after proximal deep venous thrombosis? (25944460)
2015
23
Preventing Progression of Post-Thrombotic Syndrome for Patients Post-Deep Vein Thrombosis. (26306348)
2015
24
Visceral obesity, but not metabolic syndrome, is associated with the presence of post-thrombotic syndrome. (26033396)
2015
25
Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis. (25575413)
2015
26
Theme 1: Pathogenesis of venous thromboembolism (and post-thrombotic syndrome). (26387733)
2015
27
Rutosides for treatment of post-thrombotic syndrome. (26376212)
2015
28
Rutosides for prevention of post-thrombotic syndrome. (26373375)
2015
29
Successful treatment of post thrombotic syndrome with sequential lumbar sympathetic block. (25675072)
2015
30
Quality-of-life in interventionally treated patients with post-thrombotic syndrome. (25729074)
2015
31
Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome. (26422814)
2015
32
Role of coexisting contralateral primary venous disease in development of post-thrombotic syndrome following catheter-based treatment of iliofemoral deep venous thrombosis. (26992610)
2015
33
Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene. (24485402)
2014
34
The IDEAL DVT study, individualised duration elastic compression therapy against long-term duration of therapy for the prevention of post-thrombotic syndrome: protocol of a randomised controlled trial. (25190617)
2014
35
Biomarkers for post thrombotic syndrome: a case-control study. (24975586)
2014
36
Elastic compression stockings fail to prevent post-thrombotic syndrome after a first deep vein thrombosis. (24938301)
2014
37
The post-thrombotic syndrome and compression therapy. (24843092)
2014
38
The predictive value of markers of fibrinolysis and endothelial dysfunction in the post thrombotic syndrome. A systematic review. (24500187)
2014
39
Short-term follow-up of Quality-of-Life in interventionally treated patients with post-thrombotic syndrome after deep venous occlusion. (24843095)
2014
40
Association between thrombophilia and the post-thrombotic syndrome: a systematic review and meta-analysis. (24406063)
2014
41
Impact of graduated compression stockings on the prevention of post-thrombotic syndrome - results of a randomized controlled trial. (25059736)
2014
42
Efficacy of a short course of complex lymphedema therapy or graduated compression stocking therapy in the treatment of post-thrombotic syndrome. (24558028)
2014
43
Post-thrombotic syndrome is an independent determinant of health-related quality of life following both first proximal and distal deep vein thrombosis. (24441147)
2014
44
Post-thrombotic syndrome after central venous catheter removal in childhood cancer survivors: A prospective cohort study. (25359689)
2014
45
Effect of long-term LMWH on post-thrombotic syndrome in patients with iliac/noniliac venous thrombosis: a subanalysis from the home-LITE study. (23520150)
2013
46
Extrinsic compression of left iliac vein does not predict the development of post thrombotic syndrome in left side deep venous thrombosis. (22708099)
2012
47
The future of deep venous thrombosis and post-thrombotic syndrome in 2020. (22312074)
2012
48
VenorutonAr: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with VenorutonAr. A five-year, open-registry, efficacy study. (22108472)
2011
49
Thrombophilia in patients with chronic venous leg ulcers-a study on patients with or without post-thrombotic syndrome. (21392126)
2011
50
Reflex sympathetic dystrophy secondary to deep venous thrombosis mimicking post-thrombotic syndrome. (19363611)
2009

Variations for Post-Thrombotic Syndrome

About this section

Expression for genes affiliated with Post-Thrombotic Syndrome

About this section
Search GEO for disease gene expression data for Post-Thrombotic Syndrome.

Pathways for genes affiliated with Post-Thrombotic Syndrome

About this section

Pathways related to Post-Thrombotic Syndrome according to GeneCards Suite gene sharing:

(show all 15)
idSuper pathwaysScoreTop Affiliating Genes
19.4CCL2, IL6
29.3ICAM1, IL6
39.3ICAM1, IL6
49.3ICAM1, IL6
59.3CCL2, ICAM1
6
Show member pathways
9.0CCL2, F2, IL6
7
Show member pathways
8.9CCL2, ICAM1, SERPINE1
88.8CCL2, ICAM1, IL6
98.8CCL2, ICAM1, IL6
108.8CCL2, ICAM1, IL6
118.8CCL2, ICAM1, IL6
12
Show member pathways
8.5F2, F5, F8, SERPINC1
138.4CCL2, ICAM1, IL6, SERPINE1
14
Show member pathways
8.1F2, F5, F8, SERPINC1, SERPINE1
15
Show member pathways
8.1F2, F5, F8, SERPINC1, SERPINE1

GO Terms for genes affiliated with Post-Thrombotic Syndrome

About this section

Cellular components related to Post-Thrombotic Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1ER to Golgi transport vesicleGO:003013410.2F5, F8
2platelet alpha granule lumenGO:00310939.9F5, F8, SERPINE1
3endoplasmic reticulum lumenGO:00057889.6F2, F5, F8
4extracellular regionGO:00055766.7CCL2, F2, F5, F8, IL6, SERPINC1
5extracellular spaceGO:00056156.4CCL2, F2, F5, F8, ICAM1, IL6

Biological processes related to Post-Thrombotic Syndrome according to GeneCards Suite gene sharing:

(show all 31)
idNameGO IDScoreTop Affiliating Genes
1blood coagulation, intrinsic pathwayGO:000759710.3F2, F8
2fibrinolysisGO:004273010.1F2, SERPINE1
3negative regulation of fibrinolysisGO:005191810.1F2, SERPINE1
4positive regulation of collagen biosynthetic processGO:003296710.1CCL2, F2
5regulation of vascular endothelial growth factor productionGO:001057410.0CCL2, IL6
6negative regulation of endothelial cell apoptotic processGO:200035210.0ICAM1, SERPINE1
7positive regulation of cellular extravasationGO:000269310.0CCL2, ICAM1
8cellular response to nutrient levelsGO:003166910.0ICAM1, IL6
9positive regulation of monocyte chemotaxisGO:009002610.0CCL2, SERPINE1
10monocyte chemotaxisGO:000254810.0CCL2, IL6
11response to bacteriumGO:00096179.9CCL2, IL6
12negative regulation of extrinsic apoptotic signaling pathway via death domain receptorsGO:19020429.8ICAM1, SERPINE1
13response to antibioticGO:00466779.8CCL2, IL6
14platelet degranulationGO:00025769.8F5, F8, SERPINE1
15positive regulation of blood coagulationGO:00301949.8F2, SERPINE1
16ER to Golgi vesicle-mediated transportGO:00068889.7F2, F5, F8
17acute-phase responseGO:00069539.7F2, F8, IL6
18positive regulation of nitric oxide biosynthetic processGO:00454299.6ICAM1, IL6
19acute inflammatory response to antigenic stimulusGO:00024389.4ICAM1, SERPINC1
20response to woundingGO:00096119.4CCL2, F2, IL6
21response to amino acidGO:00432009.3CCL2, ICAM1, IL6
22cellular response to dexamethasone stimulusGO:00715499.3CCL2, IL6
23cellular response to interleukin-1GO:00713479.3CCL2, ICAM1, IL6
24defense response to Gram-negative bacteriumGO:00508299.2IL6, SERPINE1
25cellular response to tumor necrosis factorGO:00713569.2CCL2, ICAM1, IL6
26response to lipopolysaccharideGO:00324969.2CCL2, ICAM1, IL6
27platelet activationGO:00301689.1F2, F5, F8, IL6
28positive regulation of ERK1 and ERK2 cascadeGO:00703748.8CCL2, ICAM1, IL6
29cellular response to lipopolysaccharideGO:00712228.8CCL2, ICAM1, IL6, SERPINE1
30regulation of cell shapeGO:00083608.6CCL2, F2, ICAM1, IL6
31blood coagulationGO:00075968.5F2, F5, F8, SERPINC1

Molecular functions related to Post-Thrombotic Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1serine-type endopeptidase activityGO:00042529.0F2, F5, F8
2receptor bindingGO:00051028.6CCL2, F2, IL6, SERPINE1

Sources for Post-Thrombotic Syndrome

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet